MSD and Eisai’s trial saw mixed success with its two primary endpoints, seeing success in progression-free survival, but ...

Traws Pharma has completed the Phase I clinical trials of tivoxavir marboxil, a single-dose drug for treating or preventing ...

The trial builds off the previous Phase Ia/II trial that saw an estimated survival rate of 52.4% at 24 months in patients ...

GlobalData epidemiologists forecast a rise in dementia cases in the US from 2.97 million in 2024 to 4.06 million by 2033.

Medidata has announced the extension of its partnership of 13 years with Tigermed to enhance clinical trial processes.

The combination regimen will be assessed as a maintenance therapy to treat extensive stage small cell lung cancer patients. Credit: Jo Panuwat D/Shutterstock. Genprex has dosed the first subject in ...

The study, from the Kaohsiung Armed Forces General Hospital in Taiwan, contained 3,909 men with ED between 2010 and 2021.

Intellia Therapeutics has dosed the first subject in the Phase III trial of NTLA-2002, to treat hereditary angioedema (HAE).

Rigel has enrolled the first subject in a Phase I trial of its oral spleen tyrosine kinase (SYK) inhibitor, fostamatinib, to ...

Tris Pharma has reported positive outcomes from its ALLEVIATE-1 Phase III trial of cebranopadol to treat moderate-to-severe ...

SalubrisBio shared interim results from an ongoing Phase II heart failure trial examining its recombinant antibody fusion protein, JK07.

The US company said that results from the Alpha-CORRECT trial saw its colon cancer diagnostic Oncodetect achieving a ...